Coraza, Ramil, SR.. E.

HRN: 22-85-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2023
CEFTRIAXONE 1G (VIAL)
06/07/2023
06/13/2023
IV
2gm
Q24
Choledocholithiasis
Waiting Final Action 
06/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2023
06/14/2023
IVT
500mg
Q8
Obstructive Jaundice Sec To Choledocholithiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: